Attached files

file filename
EX-31.1 - EX-31.1 - Diadexus, Inc.ddxs-ex311_201409307.htm
EX-10.3 - EX-10.3 - Diadexus, Inc.ddxs-ex103_20140930150.htm
EX-31.2 - EX-31.2 - Diadexus, Inc.ddxs-ex312_2014093010.htm
EX-32.2 - EX-32.2 - Diadexus, Inc.ddxs-ex322_201409306.htm
EX-32.1 - EX-32.1 - Diadexus, Inc.ddxs-ex321_201409309.htm
EX-10.2 - EX-10.2 - Diadexus, Inc.ddxs-ex102_20140930188.htm
EXCEL - IDEA: XBRL DOCUMENT - Diadexus, Inc.Financial_Report.xls
10-Q - 10-Q - Diadexus, Inc.ddxs-10q_20140930.htm

Exhibit 10.4

Kenneth C. Fang, M.D.

Dear Ken:

I am pleased to offer you the role of Chief Medical Officer of diaDexus, Inc. (the “Company”), effective October 1, 2014 (the “Start Date”).  This offer letter (the “Letter”) sets forth the terms of your employment with the Company and expires if not signed and executed by both parties by the end of the day Thursday, August 21, 2014.

Role. As Chief Medical Officer, you will have the duties and responsibilities customarily assigned to such position and such other duties and responsibilities as Board of Directors of the Company (the “Board”) and/or the Company’s principle executive officer reasonably determine from time to time.  Your primary work location will be the Company’s headquarters in South San Francisco.

Base Salary.  As of the Start Date, your initial annual base salary will be $390,000 (the “Base Salary”), less applicable payroll deductions and tax withholdings, payable on the Company’s normal payroll schedule.

Cash Hiring Bonus.  Provided you begin work by October 1, 2014, the Company will pay you a hiring bonus of $20,000 within thirty-one (31) days after your Start Date.  This hiring bonus must be repaid in full to the Company should you voluntarily terminate your employment, or should you be fired for Cause (as defined in the Company’s Key Employee Severance Benefit Plan), within twelve (12) months after your Start Date.

Cash Incentive Bonus.  You are eligible to earn an annual cash incentive bonus, with the target amount of such bonus currently equal to 40% of your base salary.  If you commence full-time employment by October 1, 2014, you will be eligible for a cash bonus for 2014 of up to 50% of your target bonus amount.  Whether or not you earn any bonus will depend on the actual achievement by you and the Company of the individual and corporate performance goals, as determined by the Board, and is subject to your continued employment through the date the bonus is paid.  In all events, any earned bonus will be paid not later than March 15 of the year following the year in which your right to such amount became vested.

Option Grant.  We will recommend that the Compensation Committee of the Board grant you a nonstatutory stock option to purchase 750,000 shares of the Company’s common stock (the “Option”), under the terms of the Company’s current equity incentive plan (the “Plan”). The Option will be subject to vesting based on your continued service, with 1/4 of the total number of shares becoming vested on the first anniversary of your Start Date, and 1/48 of the total number of shares vesting each month thereafter, so the Option would become fully vested over four years.

Employee Benefits.  During your employment with the Company, you will be eligible to participate in the health insurance and other employee benefit plans made available to employees of the Company under the terms of such plans, as they are in effect from time to time by the Company.

Expense Reimbursement.  As an officer, you are authorized to incur ordinary and necessary business expenses in the course of your duties.  Any reimbursements will be paid to you within 30 days after the date you submit receipts for the expenses, provided you submit those receipts within 60 days after you incur the expense.  If any reimbursements payable to you are subject to the provisions of Section 409A of the Code, any such reimbursements will be paid no later than December 31 of the year following the year in which the expense was incurred, the amount of expenses reimbursed in one year will not affect the amount eligible for reimbursement in any subsequent year, and the right to reimbursement will not be subject to liquidation or exchange for another benefit.

At-Will Employment.  Your employment with the Company is on an “at-will” basis, meaning that either the Company or you may terminate your employment at any time, with or without cause or advance notice.

Severance Benefits.  Consistent with your position as Chief Medical Officer, the Compensation Committee has designated you as a Tier 2 participant in the Company’s Key Employee Severance Benefit Plan, which provides for severance on an involuntary termination of employment.  We are providing a copy of the Key Employee Severance Benefit Plan with this Letter.  To accept your designation as a Participant in the Key Employee Severance Benefit Plan, you must sign and return the Participation Notice within 30 days after your Start Date.  Capitalized terms used in this paragraph but not defined in this Letter have the meaning set forth in the Key Employee Severance Benefit Plan.

Proprietary Information.  As a condition of your employment with the Company, you must sign and abide by the Company’s Proprietary Information and Inventions Assignment Agreement (the “Proprietary Information Agreement”), a copy of which is attached.

 

 


Obligations.  While employed with the Company, you agree to devote your entire business time, attention and energies to the business and interests of the Company.  By accepting employment, you agree to abide by the rules, regulations, instructions, personnel practices and policies of the Company and any changes therein which may be adopted from time to time by the Company.

Section 409A. It is intended that all of the benefits and payments under this Letter satisfy, to the greatest extent possible, the exemptions from the application of Code Section 409A provided under Treasury Regulations 1.409A‑1(b)(4), 1.409A‑1(b)(5) and 1.409A‑1(b)(9), and this Letter will be construed to the greatest extent possible as consistent with those provisions.  If not so exempt, this Letter (and any definitions hereunder) will be construed in a manner that complies with Section 409A, and incorporates by reference all required definitions and payment terms.  For purposes of Code Section 409A (including, without limitation, for purposes of Treasury Regulation Section 1.409A‑2(b)(2)(iii)), your right to receive any installment payments under this Letter (whether severance payments, reimbursements or otherwise) will be treated as a right to receive a series of separate payments and, accordingly, each installment payment hereunder will at all times be considered a separate and distinct payment.  This Letter (including the attachments) sets forth the complete and exclusive agreement between you and the Company with regard to your employment with the Company and supersedes any prior representations or agreements about this matter, whether written or verbal.  This Letter may not be modified or amended except by a written agreement signed by you and a member of the Board.  This Letter is governed by California law.  As required by law, this offer of employment is subject to the satisfactory proof of your right to work in the United States on or prior to your Start Date.

Let me again express how pleased we are to extend this offer to you, and how much we look forward to working with you.  Please review this Letter carefully and let me know if you have any questions.  If this Letter is acceptable to you, please sign it below.

 

 

Very truly yours,

 

 

/s/ Alexander L. Johnson

 

 

Alex Johnson
President

 

diaDexus, Inc.

 

Accepted and agreed:

 

 

/s/ Kenneth C. Fang, M.D.

 

Kenneth C. Fang, M.D.

 

 

August 21, 2014

 

Date